A biotech company is beginning trials for a fentanyl vaccine. The CEO says it ‘could completely change’ how overdoses are treated
by .

Human trials are scheduled to begin in the Netherlands early next year
Human trials are scheduled to begin in the Netherlands early next year
Recent Posts
- 200,000 children under the age of 5 to die this year because of foreign aid cuts
- Salisbury Novichok latest: Dawn Sturgess inquiry ‘set to criticise MI5’ over Russian spy poisoning
- Australia sentences ‘Asia’s El Chapo’ to 16 years in prison
- NASCAR antitrust trial: Bob Jenkins testifies about $100M loss and ‘insulting’ charter deal
- UK energy bills to rise by £108 to pay for infrastructure upgrades